Kopernik Global Investors LLC Invests $44.52 Million in Concentrix Corporation $CNXC

Kopernik Global Investors LLC acquired a new position in Concentrix Corporation (NASDAQ:CNXCFree Report) in the 1st quarter, Holdings Channel reports. The institutional investor acquired 1,627,306 shares of the company’s stock, valued at approximately $44,523,000. Concentrix comprises 3.1% of Kopernik Global Investors LLC’s portfolio, making the stock its 13th biggest holding.

A number of other hedge funds also recently bought and sold shares of the company. First Trust Advisors LP lifted its holdings in Concentrix by 11.1% in the first quarter. First Trust Advisors LP now owns 895,118 shares of the company’s stock valued at $24,490,000 after acquiring an additional 89,220 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Concentrix by 18.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,951,378 shares of the company’s stock valued at $80,746,000 after purchasing an additional 460,108 shares during the period. Kera Capital Partners Inc. bought a new stake in shares of Concentrix during the 1st quarter valued at about $322,000. Bank of New York Mellon Corp increased its position in shares of Concentrix by 6.1% during the 1st quarter. Bank of New York Mellon Corp now owns 753,086 shares of the company’s stock valued at $20,604,000 after purchasing an additional 43,316 shares during the last quarter. Finally, Advisors Preferred LLC purchased a new stake in shares of Concentrix during the 1st quarter valued at about $725,000. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Price Performance

Shares of NASDAQ:CNXC opened at $23.89 on Thursday. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.18 and a quick ratio of 1.18. Concentrix Corporation has a 1-year low of $19.12 and a 1-year high of $62.14. The company has a market capitalization of $1.46 billion, a P/E ratio of -1.12, a P/E/G ratio of 0.44 and a beta of 0.47. The firm’s 50 day simple moving average is $25.11 and its two-hundred day simple moving average is $30.03.

Concentrix (NASDAQ:CNXCGet Free Report) last posted its quarterly earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The firm had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.47 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.70 earnings per share. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Research analysts expect that Concentrix Corporation will post 9.67 EPS for the current fiscal year.

Concentrix Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Investors of record on Friday, July 24th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Friday, July 24th. This represents a $1.44 annualized dividend and a yield of 6.0%. Concentrix’s dividend payout ratio is currently -6.75%.

Insider Transactions at Concentrix

In other Concentrix news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total value of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares in the company, valued at approximately $61,714,090.75. This represents a 68.39% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on CNXC. Wall Street Zen downgraded shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Canaccord Genuity Group decreased their price target on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Robert W. Baird reduced their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Finally, Bank of America lowered their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research report on Tuesday, June 30th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $32.75.

View Our Latest Report on Concentrix

Concentrix Profile

(Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Further Reading

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXCFree Report).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.